Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their ...

Treating and managing type 2 diabetes successfully can require a team. Learn from these specialists how to hit your health ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s ...

Patients with severe mental disorder and diabetes may be exposed to inappropriate polypharmacy increasing the risk of side effects and drug interactions. Although medication reviews may facilitate ...

Prioritize monitoring: Monitoring your health regularly is essential for managing diabetes. Keeping track of your diet, A1C, ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk.

In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...